All News #Library
Others
BrainVectis gains approval for Phase I/II Huntington’s gene therapy trial
24 Aug 2022 //
CLINICALTRIALSARENA
BrainVectis receives clearance to conduct PI/II trial for its novel gene therapy
23 Aug 2022 //
PRNEWSWIRE

Market Place
Sourcing Support